soravar 200 film coated tablet 200 mg
accord healthcare private limited - sorafenib tosylate eqv to sorafenib - tablet, film coated - sorafenib tosylate eqv to sorafenib 200 mg
balversa tablet
janssen inc - erdafitinib - tablet - 3mg - erdafitinib 3mg - antineoplastic agents
balversa tablet
janssen inc - erdafitinib - tablet - 4mg - erdafitinib 4mg - antineoplastic agents
balversa tablet
janssen inc - erdafitinib - tablet - 5mg - erdafitinib 5mg - antineoplastic agents
balversa tablet
janssen inc - erdafitinib - tablet - 4mg - erdafitinib 4mg - antineoplastic agents
sunitinib sandoz 12.5 mg hard capsules
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents
sunitinib sandoz 25 mg hard capsules
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents
sunitinib sandoz 50 mg hard capsules
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastic agents - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
imbruvica film-coated tablets 140mg
johnson & johnson international (singapore) pte ltd - ibrutinib - tablet, film coated - ibrutinib 140mg